HIV drug shows potential to combat form of dystonia in preclinical study
In mouse-model research, HIV medication restored brain abnormalities in DYT1 dystonia.
In mouse-model research, HIV medication restored brain abnormalities in DYT1 dystonia.
Researchers launch study to aid in quick and accurate early Parkinson’s diagnosis versus two related but distinct disorders.
The program trains doctoral students to become independent researchers in Parkinson’s disease, dystonia, tremor and ataxia.
Dr. David Vaillancourt leads international study demonstrating that a non-invasive, automated MRI method can pinpoint various types of Parkinson’s disease and Parkinson’s-like syndromes.
National Institute of Neurological Disorders and Stroke leadership recently visited with Predoctoral Interdisciplinary Training in Movement Disorders and Neurorestoration program participants.
In the laboratory of David Vaillancourt, Ph.D., researchers are applying a groundbreaking, noninvasive imaging biomarker they identified to discover better diagnostics and treatment of Parkinson's disease.
A review by Dr. David Vaillancourt, a member of the MBI's executive committee, was recently featured on the cover of the journal Movement Disorders.